N. SGHERZA, P. CURCI, V. STRAFELLA, R. RIZZI, and P. MUSTO, “Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma”, Acta Biomed, vol. 92, no. 2, p. e2021205, May 2021, doi: 10.23750/abm.v92i2.11395.